Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2010
08/26/2010US20100215759 Pharmaceutical compounds
08/26/2010US20100215756 Pharmaceutical preparations containing highly volatile silicones
08/26/2010US20100215741 Pharmaceutical compounds
08/26/2010US20100215734 Pharmaceutical compositions
08/26/2010US20100215693 Immunological herpes simplex virus antigens and methods for use thereof
08/26/2010US20100215685 Acyl pseudodipeptides which carry a functionalized auxiliary arm
08/26/2010US20100215684 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
08/26/2010US20100215683 Protective antigens for group b streptococcus hypervirulent strains
08/26/2010US20100215682 Deletion of the beta 20-21 loop in hiv gp120 exposes the cd4 binding site for improved antibody binding and antibody induction
08/26/2010US20100215679 Methods and compositions for treating tularemia
08/26/2010US20100215677 Pdz domain interactions and lipid rafts
08/26/2010US20100215667 Methods and compositions of treatment for modulating the immune system of animals
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215657 Methods and Compositions Using Klotho-FGF Fusion Polypeptides
08/26/2010US20100215653 Methods of treating neoplastic, autoimmune and inflammatory diseases
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215649 Antibodies for norovirus
08/26/2010US20100215621 Recombinant Adenoviruses Capable Of Regulating Angiogenesis
08/26/2010US20100215619 Hla peptide therapy
08/26/2010US20100215614 Enterostatin as Inhibitor of Angiogenesis
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010US20100215572 Methods of treatment using ldcam
08/26/2010CA2789515A1 Treatment of chronic inflammatory conditions
08/26/2010CA2786891A1 Immunopotentiating composition and process for producing same
08/26/2010CA2753280A1 Anti-human .alpha.9 integrin antibody and use thereof
08/26/2010CA2753048A1 Streptavidin having low immunogenicity and use thereof
08/26/2010CA2752961A1 Glycolipid mixture with antiinflammatory acivity obtained from oscillatoria planktothrix
08/26/2010CA2752869A1 Compositions for treating an allergic or asthmatic condition
08/26/2010CA2751477A1 Antibody molecules having specificity for human ox40
08/26/2010CA2750477A1 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists
08/25/2010EP2221377A1 Oligonucleotide compositions with enhanced efficiency
08/25/2010EP2221364A1 Compositions for treating an allergic or asthmatic condition
08/25/2010EP2221316A1 Anti-CD19 antibody therapy for autoimmune disease
08/25/2010EP2221314A1 A soluble tumor necrosis factor receptor mutant
08/25/2010EP2221291A1 Cyclohexenone compounds from antrodia camphorata and pharmaceutical compositions thereof useful for treating autoimmune diseases
08/25/2010EP2220122A2 Humanized antibodies against tl1a
08/25/2010EP2220077A1 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases
08/25/2010EP2220044A1 P38 map kinase inhibitors
08/25/2010EP2220037A1 Synthetic sphingolipid analogs
08/25/2010EP2220029A1 Novel compounds
08/25/2010EP2219669A1 Compositions and methods for treatment of autoimmune and allergic diseases
08/25/2010EP2219629A1 Novel compounds as cannabinoid receptor ligands
08/25/2010EP2219627A2 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
08/25/2010EP2219609A2 Immuno-modulatory composition
08/25/2010EP1942925B1 Methods for fusion polypeptide delivery into a cell
08/25/2010EP1789091B1 Prodrugs containing novel bio-cleavable linkers
08/25/2010EP1637531B1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
08/25/2010EP1469882B1 Treatment of nervous system diseases with goat serum
08/25/2010EP1404367B1 Use of polyclonal anti-hiv goat serum as a therapeutic agent
08/25/2010EP1363632B1 Receptor selective cannabimimetic aminoalkylindoles
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010EP1263722B1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
08/25/2010EP1263721B1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
08/25/2010EP1181047B9 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
08/25/2010EP1042286B1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
08/25/2010CN1879875B Preparations stabilized over long time
08/25/2010CN1872095B Drop pills of enhancing body immunity and fighting against senium
08/25/2010CN1785285B Extraction method of hawthorn leaf
08/25/2010CN1771984B New use of extracellular polysaccharide of halophilous aphanothece
08/25/2010CN1665524B Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
08/25/2010CN101815707A oxadiazole diaryl compounds
08/25/2010CN101815532A Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient
08/25/2010CN101812491A Method for producing pleurotus ferulae polysaccharide and oral liquid thereof through fermentation
08/25/2010CN101812136A Method for preparing astragalus polysaccharide extract
08/25/2010CN101812008A IDO inhibitor containing pyrrole-2-aryl structure and preparation method thereof
08/25/2010CN101810859A Medical composition containing aniline derivative
08/25/2010CN101810850A Mouth spraying agent containing cell growth factor and production method thereof
08/25/2010CN101810848A Traditional Chinese medicinal composite for reducing stress response of aquatic animals and preparation method and application thereof
08/25/2010CN101810847A Inflammation-inhibiting compounds
08/25/2010CN101810844A External plaster for preventing disease and manufacturing method thereof
08/25/2010CN101810817A Formula of Chinese medicament for treating myasthenia of limbs
08/25/2010CN101810794A Composition of natural plant extracts with anti-allergic effects and preparation method and use thereof
08/25/2010CN101810766A Chinese medicinal composition and preparation method and application thereof
08/25/2010CN101810717A Livestock traditional Chinese medicine composition with function of clearing heat and detoxicating, preparation method and application
08/25/2010CN101810690A Livestock Chinese medicinal composition for enhancing body immunity and preparation method thereof
08/25/2010CN101810674A Chinese medicinal composition for enhancing immunity, and preparation method thereof
08/25/2010CN101810659A Total saponins of salvia chinensis benth, and medical application and preparation method thereof
08/25/2010CN101810657A American ginseng contained composition and American ginseng tea drink
08/25/2010CN101810644A Production method of ant essential oil and ant oil soft capsule
08/25/2010CN101810643A Goose gall extract, preparation method and medicine use thereof
08/25/2010CN101810615A Azatadine-containing composition
08/25/2010CN101810609A Medicinal composition for enhancing immunity of cow and controlling mastitis
08/25/2010CN101810605A Salvianic acid A pharmaceutical composition and preparation method thereof
08/25/2010CN101810563A Tacrolimus ophthalmic in-situ gel preparation and preparation method thereof
08/25/2010CN101810562A Nasal in situ gel containing cortical hormone
08/25/2010CN101810560A Cyclosporine A polymeric micelles composition
08/25/2010CN101375850B Application of norisoboldine in preparing medicament for treating autoimmune disease
08/25/2010CN101028305B Ganoderic spore extract and its production
08/25/2010CA2694692A1 Compositions of spores of non pathogenic bacteria
08/24/2010US7781617 medicine comprises a combination of a diaryl sulfide or diaryl ether compound having a 2-amino-1,3-propanediol structure; 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propanediol; immunosuppressant or anti-inflammatory agent and is effective in diminishing the occurrence of side effects
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781584 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010US7781450 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer
08/24/2010US7781447 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
08/24/2010US7781175 Modulators for to a G protein-coupled receptor protein using the receptor protein and a cholesterol metabolism-related substance; kits; signal transduction modulators
08/24/2010US7780959 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2460135C Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 1172